Science

Breast Cancer Study Shows Reversal of Estrogen Receptor Gene Programs

Rinath Jeselsohn/X

Aug 18, 2025, 12:53

Breast Cancer Study Shows Reversal of Estrogen Receptor Gene Programs

Dana-Farber’s Breast Oncology Center shared a post on X:

“Check out this recent study from Dr. Rinath Jeselsohn and colleagues

Combined inhibition of KAT6A/B and Menin reverses estrogen receptor-driven gene expression programs in Breast Cancer.”

Breast Cancer

Title: Combined inhibition of KAT6A/B and Menin reverses estrogen receptor-driven gene expression programs in breast cancer

Authors: Sarah Naomi Olsen, Bryn Anderson, Charlie Hatton, Zhengtao Chu, Christopher Simpkins, Yanhe Wen, Wallace Bourgeois, Elena L Haarer, Myles Brown, Rinath Jeselsohn, Alana L Welm, Eneda Toska, Scott A Armstrong

Read Full Article.

Breast Cancer Study Shows Reversal of Estrogen Receptor Gene Programs

More posts featuring Dana-Farber’s Breast Oncology Center on OncoDaily.

Alana L. Welm Breast Cancer Bryn Anderson cancer Charlie Hatton Christopher Simpkins Dana-Farber’s Breast Oncology Center Elena L Haarer Eneda Toska Myles Brown OncoDaily Oncology Rinath Jeselsohn Sarah Naomi Olsen Scott A. Armstrong Wallace Bourgeois Yanhe Wen Zhengtao Chu

Ruben Mesa is Starting a New Position as President of Cancer National Service Line at Advocate Health

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter

Dana Dornsife: After 19 Years, Lazarex Cancer Foundation Is Shuttering Because of Lack of Funding

Matt Sherer: ASCO Supports Permanent Medicare Telehealth

New FDA PreCheck Program to Boost U.S. Drug Manufacturing